Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 0

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Amendment No. 1to SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☒ Preliminary Proxy Statement

☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☐ Definitive Additional Materials

☐ Soliciting Material under §240.14a-12

<div align='center'>MIRA Pharmaceuticals, Inc.

(Exact name of Registrant as specified in its charter)</div>

Payment of Filing Fee (Check the appropriate box)

☐ No fee required

☒ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

<div align='center'>MIRA Pharmaceuticals, Inc.

1200 Brickell Avenue

Suite 1950 #1183

Miami, FL 33131

(786) 423-9792

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</div>

To the Stockholders of MIRA Pharmaceuticals, Inc.:

You are cordially invited to attend a virtual annual meeting of the stockholders of MIRA Pharmaceuticals, Inc., a Florida corporation, which we refer to as “we”, “MIRA”, or the “Company”, which will be held exclusively online via live audio-only webcast at http://web.lumiconnect.com//241-211-965on September 11, 2025, at Eastern Time, unless postponed or adjourned to a later date (the “MIRA Annual Meeting”). This is an important meeting that affects your investment in MIRA.

MIRA is holding the Annual Meeting to obtain the stockholder approvals necessary for certain matters, including to complete the Merger and related matters. MIRA has chosen to hold an exclusively virtual annual meeting rather than an in-person meeting to allow for greater access to those who may want to attend. Any stockholder entitled to attend and vote at the MIRA Annual Meeting is entitled to appoint a proxy to attend and vote on such stockholder’s behalf. Such proxy need not be a